NasdaqGM:NPCEMedical Equipment
NeuroPace (NPCE) Loss Narrowing In Q4 Tests Bullish Profitability Narrative
NeuroPace (NPCE) has just closed out FY 2025 with Q4 revenue of US$26.6 million and a basic EPS loss of US$0.08, while trailing twelve month figures show revenue of US$100.0 million and a basic EPS loss of US$0.66 as the company continues to operate at a loss. Over the past several quarters, the business has seen revenue move from US$21.5 million in Q4 2024 to US$26.6 million in Q4 2025, with quarterly basic EPS losses ranging between US$0.18 and US$0.26 before the latest US$0.08 print. This...